Tag Archives: Biotechnology Industry Organization (BIO) IP & Diagnostic Symposium

At the end of September 2014, at the Biotechnology Industry Organization (BIO) IP & Diagnostic Symposium, attendees learned additional information regarding the new United States Patent and Trademark Office (USPTO) guidelines, which were supposed to be released by the end of October. Unfortunately,  we are now at the end of November and the guidelines still […]